Table 1 Characteristics of included studies
Study | Country | Sample type | Sample size | Control subjects | AFP | Method of detection | Cut off value | TP | FP | FN | TN |
|---|---|---|---|---|---|---|---|---|---|---|---|
Mashaly et al., 2018 [16] | Egypt | Serum | 22 | HC (n = 30) | Negative | ELISA | 1.683 ng/ml | 17 | 5 | 4 | 26 |
Shaheen et al., 2015 [19] | Egypt | Serum | 15 | HC (n = 26) | Negative | ELISA | 0.387 ng/ml | 14 | 5 | 1 | 25 |
Zhu et al., 2013 [14] | China | Serum | 181 | HC (n = 395) | Negative | ELISA | 0.654 ng/ml | 108 | 73 | 13 | 382 |
Vongsuvanh et al., 2016 [18] | Australia | Serum | 49 | HC (n = 86) | Negative | ELISA | 0.44 ng/ml | 29 | 20 | 33 | 53 |
El-Shayeb et al., 2021 [22] | Egypt | Serum | 19 | LC (n = 89) | Negative | ELISA | 5.1 ng/ml | 19 | 0 | 9 | 80 |